ArticleDrug safety2026

The Value of Time-to-Onset for Signal Validation: Experience from the Reporting of COVID-19 Vaccines and Glomerular Diseases in VigiBase.

Annette Rudolph et al.PubMed ↗Publisher ↗

No numbers read from the abstract.